Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 10 of 14 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Show all pathways known for 2.3.1.241Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.241Arthritis 21088052 Neisseria meningitidis lipid A mutant LPSs function as LPS antagonists in humans by inhibiting TLR 4-dependent cytokine production. causal interaction
therapeutic application
unassigned
1
1
0
Show all pathways known for 2.3.1.241Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.241Exanthema 19390612 Naturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. causal interaction
diagnostic usage
ongoing research
therapeutic application
3
1
3
1
Show all pathways known for 2.3.1.241Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.241Hepatitis B 18982519 Enhancement of T-helper type I immune responses against hepatitis B surface antigen by LPS derivatives adjuvanted liposomes delivery system. diagnostic usage
ongoing research
unassigned
3
2
0
Show all pathways known for 2.3.1.241Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.241Infections 20439476 The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal disease. ongoing research
therapeutic application
unassigned
2
2
0
Show all pathways known for 2.3.1.241Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.241Influenza, Human 19059296 Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity. causal interaction
diagnostic usage
ongoing research
therapeutic application
1
3
2
3
Show all pathways known for 2.3.1.241Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.241Meningitis 22261040 Invasive meningococcal capsular group y disease, England and Wales, 2007-2009. causal interaction
diagnostic usage
unassigned
1
2
0
Show all pathways known for 2.3.1.241Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.241Meningitis, Meningococcal 19390612 Naturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. causal interaction
diagnostic usage
ongoing research
therapeutic application
3
1
3
1
Show all pathways known for 2.3.1.241Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.241Meningococcal Infections 28024455 The Neisseria meningitidis lpxL1 mutant induces less tissue factor expression and activity in primary human monocytes and monocyte-derived microvesicles than the wild type meningococcus. ongoing research
unassigned
1
0
Show all pathways known for 2.3.1.241Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.241Meningococcal Infections 29313733 Whole-blood incubation with the Neisseria meningitidis lpxL1 mutant induces less pro-inflammatory cytokines than the wild type, and IL-10 reduces the MyD88-dependent cytokines. therapeutic application
unassigned
1
0
Show all pathways known for 2.3.1.241Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.241Neoplasms 11553534 Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. diagnostic usage
therapeutic application
unassigned
1
2
0
Results 1 - 10 of 14 > >>